Categories
Disease Modifying Anti-rheumatic Drugs,DMARDs Golimumab Pharmacology Physiotherapy

Golimumab and Autoimmune Disorders and Autoantibodies

In this article we will discuss Golimumab and Autoimmune Disorders and Autoantibodies

In this article, we will discuss Golimumab and Autoimmune Disorders and Autoantibodies. So, let’s get started.

Golimumab and Autoimmune Disorders and Autoantibodies

The use ofTNF-blockers, including Golimumab, has been associated with the formation of autoantibodies and, rarely, with the development of a lupus-like syndrome. In the controlled Phase 3 trials in patients with RA, PsA, and AS through Week 14, there was no association of Golimumab treatment and the development of newly positive anti-dsDNA antibodies.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.